ClinConnect ClinConnect Logo
Search / Trial NCT06910735

Financial Incentives and Weight Loss in Failed Bariatric Surgery

Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Mar 28, 2025

Trial Information

Current as of August 20, 2025

Not yet recruiting

Keywords

Bariatric Surgery Financial Incentive

ClinConnect Summary

This clinical trial is looking at how financial incentives can help people who have regained weight after having weight loss surgery, such as gastric bypass or sleeve gastrectomy. The goal is to see if offering money or rewards for losing weight can motivate individuals to shed those extra pounds. The researchers will also analyze the costs and benefits of this approach to see if it could be useful on a larger scale in the future.

To participate in this study, individuals need to be at least 18 years old and have undergone one of the mentioned weight loss surgeries more than two years ago. They should have gained back at least 10% of the weight they initially lost and still have a body mass index (BMI) of 30 or higher, which means they are classified as obese. Participants can expect to receive support and possibly financial rewards for reaching their weight loss goals. It's important to note that pregnant women and those planning to become pregnant within the year of the study are not eligible to join.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Male or female over 18 years of age
  • Patients with a history of adjustable gastric banding, sleeve gastrectomy, gastric bypass or SADI-sleeve surgery
  • Patient with a post-operative delay of more than 2 years
  • Patient who has gained ≥10% of the maximum weight lost
  • Patient still obese (body mass index ≥ 30 kg/m²) after surgery
  • Exclusion Criteria:
  • Pregnant women
  • Women of childbearing potential planning a pregnancy during the first year of the study
  • Persons under legal protection (safeguard of justice, guardianship, curatorship, etc.)

About Assistance Publique Hôpitaux De Paris

Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.

Locations

Poitiers, , France

Créteil, , France

Paris, , France

Vandœuvre Lès Nancy, , France

Paris, , France

Paris, , France

Bobigny, , France

Colombes, , France

Marseille, , France

Nantes, , France

Orléans, , France

Reims, , France

Patients applied

0 patients applied

Trial Officials

Sébastien Czernichow, MD

Principal Investigator

Assistance Publique - Hôpitaux de Paris

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported